Minimally Invasive Closure of Umbilical Hernias (MIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00706329|
Recruitment Status : Terminated (The study was terminated prematurely by the IRB due to data integrity and protocol compliance issues)
First Posted : June 27, 2008
Results First Posted : August 28, 2013
Last Update Posted : November 6, 2017
|Condition or disease||Intervention/treatment||Phase|
|Umbilical Hernia||Device: Deflux||Not Applicable|
All patients will undergo general anesthesia for their primary procedure, i.e. inguinal hernia repair. Once under general anesthesia, the abdomen will be prepped and draped in the usual sterile surgical fashion. The edge of the umbilical hernia defect will be palpated and in case there are any contents of the hernia present, they will be pushed into the abdominal cavity. Adequate relaxation, again, will be assured. A 24 gauge needle will be used to inject 1cc of Deflux ("Study Product") into each quadrant at the junction between the preperitoneal space and the inner palpable rim of the fascial defect. The surgeon's index finger stays in the center of the hernia defect, protecting the hernia sac contents from re-herniating. Closure of the umbilical defect will be confirmed by palpation immediately after injection. A sterile wound dressing will be applied and the primary surgical procedure will be performed afterwards.
Definition of Primary and Secondary Outcomes/Endpoints:
The endpoint of this study is closure of the umbilical hernia.
Data Collection Methods, Assessments, and Schedule (what assessments performed, how often): A data collection file is started at the time of enrollment in the study. Data collection includes patient age, gender, and weight at the time of operation, inner diameter of the umbilical hernia defect at the time of operation, description of the immediate postoperative results and follow-up exams at two weeks, one month, and six months.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Study of Minimally Invasive Closure of Umbilical Hernias|
|Study Start Date :||April 2008|
|Actual Primary Completion Date :||March 2009|
|Actual Study Completion Date :||March 2009|
Treatment with Deflux.
Patients undergo surgery using Deflux to correct umbilical hernia
- Close Belly Button or Umbilical Hernia [ Time Frame: After surgery, subjects will be followed at intervals of one month and six months from date of surgery. ]The study was terminated prematurely by the IRB. Results are not shared due to data integrity concerns. These concerns are outlined in an FDA warning letter.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00706329
|United States, Massachusetts|
|Children's Hospital Boston and South Shore Hospital|
|South Weymouth, Massachusetts, United States, 02190|
|Principal Investigator:||Neil R. Feins, M.D.||Children's Hospital Boston and South Shore Hospital|